UNLABELLED: In this prospective cohort study, depressive symptoms were associated with higher rates of bone loss in older men. Poorer performance on physical function tests partly explained the association between depressive symptoms and bone loss, suggesting that efforts to increase exercise and improve physical performance in depressed men may be beneficial. INTRODUCTION: The aim of this study was to ascertain whether depressive symptoms are associated with increased rates of bone loss at the hip in older men. METHODS: A population-based prospective cohort study of 2,464 community-dwelling men, aged 68 and older, enrolled in the Osteoporosis in Men Sleep Ancillary Study had depressive symptoms assessed by the Geriatric Depression Scale (GDS). Subjects were categorized as depressed if GDS ≥6 at the initial examination. Bone mineral density (BMD) at the hip was measured using dual-energy X-ray absorptiometry at the initial and follow-up examination (average 3.4 years between exams). Use of antidepressant medications was assessed by interview and verified from medication containers at the two examinations. A computerized dictionary was used to categorize type of medication. RESULTS: In a base model adjusted for age, race/ethnicity, and clinic site, the mean total hip BMD decreased 0.70 %/year in 136 men with a GDS score of ≥6 compared to 0.39 %/year in 2,328 men with a GDS score of <6 (p = 0.001). Walking speed and timed chair stand partly explained the association between depressive symptoms and rates of bone loss. CONCLUSION: Depression, as defined by a score of 6 or greater on the Geriatric Depression Scale, is associated with an increased rate of bone loss at the hip in this cohort of older men. Adjustment for walking speed and timed chair stand attenuated the strength of the association, suggesting that differences in physical functioning do partially explain the observed association.
UNLABELLED: In this prospective cohort study, depressive symptoms were associated with higher rates of bone loss in older men. Poorer performance on physical function tests partly explained the association between depressive symptoms and bone loss, suggesting that efforts to increase exercise and improve physical performance in depressedmen may be beneficial. INTRODUCTION: The aim of this study was to ascertain whether depressive symptoms are associated with increased rates of bone loss at the hip in older men. METHODS: A population-based prospective cohort study of 2,464 community-dwelling men, aged 68 and older, enrolled in the Osteoporosis in Men Sleep Ancillary Study had depressive symptoms assessed by the Geriatric Depression Scale (GDS). Subjects were categorized as depressed if GDS ≥6 at the initial examination. Bone mineral density (BMD) at the hip was measured using dual-energy X-ray absorptiometry at the initial and follow-up examination (average 3.4 years between exams). Use of antidepressant medications was assessed by interview and verified from medication containers at the two examinations. A computerized dictionary was used to categorize type of medication. RESULTS: In a base model adjusted for age, race/ethnicity, and clinic site, the mean total hip BMD decreased 0.70 %/year in 136 men with a GDS score of ≥6 compared to 0.39 %/year in 2,328 men with a GDS score of <6 (p = 0.001). Walking speed and timed chair stand partly explained the association between depressive symptoms and rates of bone loss. CONCLUSION:Depression, as defined by a score of 6 or greater on the Geriatric Depression Scale, is associated with an increased rate of bone loss at the hip in this cohort of older men. Adjustment for walking speed and timed chair stand attenuated the strength of the association, suggesting that differences in physical functioning do partially explain the observed association.
Authors: W Jack Rejeski; Anthony P Marsh; Elizabeth Chmelo; Abbie J Prescott; Meredith Dobrosielski; Michael P Walkup; Mark Espeland; Michael E Miller; Stephen Kritchevsky Journal: J Gerontol A Biol Sci Med Sci Date: 2009-01-30 Impact factor: 6.053
Authors: Jian Sheng Chen; Ian D Cameron; Robert G Cumming; Stephen R Lord; Lyn M March; Philip N Sambrook; Judy M Simpson; Markus J Seibel Journal: J Bone Miner Res Date: 2005-10-24 Impact factor: 6.741
Authors: Stuart J Warden; Alexander G Robling; Elizabeth M Haney; Charles H Turner; Michael M Bliziotes Journal: Bone Date: 2009-07-08 Impact factor: 4.398
Authors: Heather E Whitson; Linda Sanders; Carl F Pieper; Deborah T Gold; Alexandra Papaioannou; J Brent Richards; Jonathan D Adachi; Kenneth W Lyles Journal: Aging Clin Exp Res Date: 2008-12 Impact factor: 3.636
Authors: Leslie Spangler; Delia Scholes; Robert L Brunner; John Robbins; Susan D Reed; Katherine M Newton; Jennifer L Melville; Andrea Z Lacroix Journal: J Gen Intern Med Date: 2008-02-20 Impact factor: 5.128
Authors: Susan J Diem; Terri L Blackwell; Katie L Stone; Kristine Yaffe; Jane A Cauley; Mary A Whooley; Kristine E Ensrud Journal: J Am Geriatr Soc Date: 2007-06 Impact factor: 5.562
Authors: Gillian E Mead; Wendy Morley; Paul Campbell; Carolyn A Greig; Marion McMurdo; Debbie A Lawlor Journal: Cochrane Database Syst Rev Date: 2009-07-08
Authors: M L O Shea; L D Garfield; S Teitelbaum; R Civitelli; B H Mulsant; C F Reynolds; D Dixon; P Doré; E J Lenze Journal: Osteoporos Int Date: 2013-01-29 Impact factor: 4.507
Authors: Marie Anne Gebara; Marcie L O Shea; Kim L Lipsey; Steven L Teitelbaum; Roberto Civitelli; Daniel J Müller; Charles F Reynolds; Benoit H Mulsant; Eric J Lenze Journal: J Am Geriatr Soc Date: 2014-07-15 Impact factor: 5.562
Authors: B Kadriu; P W Gold; D A Luckenbaugh; M S Lener; E D Ballard; M J Niciu; I D Henter; L T Park; R T De Sousa; P Yuan; R Machado-Vieira; C A Zarate Journal: Mol Psychiatry Date: 2017-05-30 Impact factor: 15.992